New transfusion strategies: Red cell substitutes

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 337-353

  Winslow, Robert M ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Blood substitutes; Fluorocarbons; Hemoglobin; Oxygen carriers; Oxygen transport

Indexed keywords

BLOOD SUBSTITUTE; FLUOROCARBON; HEME; HEMOGLOBIN; LIPOSOME; NITRIC OXIDE;

BLOOD FLOW; BLOOD VOLUME; EMERGENCY MEDICINE; EMULSION; ERYTHROCYTE; OXYGEN TRANSPORT; PLASMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; TRANSFUSION;

BLOOD CIRCULATION; BLOOD SUBSTITUTES; BLOOD VOLUME; CLINICAL TRIALS; DRUG APPROVAL; EMERGENCIES; EMULSIONS; ERYTHROCYTE TRANSFUSION; FLUOROCARBONS; FREE RADICAL SCAVENGERS; HEMOGLOBINS; HUMANS; LIPOSOMES; MICROCIRCULATION; NITRIC OXIDE; OXYGEN; PLASMA SUBSTITUTES;

EID: 0033022326     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.337     Document Type: Review

References (41)

1. 1. Winslow RM. 1992. Hemoglobin-Based Red Cell Substitutes. Baltimore, MD: Johns Hopkins Univ. Press. 242 pp.
2. 2. Hess JR, Riess RF. 1996. Resuscitation and the limited utility of the present generation of blood substitutes. Transfus. Med. Rev. 10:276-85
3. 3. Rudolph AS. 1995. Encapsulation of hemoglohin in liposomes. In Blood Substitutes: Physiological Basis of Efficacy, ed. RM Winslow, KD Vandegriff, M Intaglietta, 7:90-104. Boston: Birkhauser. 205 pp.
4. 4. Iwasaki K, Iwashita Y. 1986. Preparation and evaluation of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artif. Org. 10:411-16
5. 5. Dellacherie E, Bonneaux F, Labrude P, Vigneron C. 1983. Modification of human hemoglobin by covalent association with soluble dextran. Biochim. Biophys. Acta 749:106-14
6. 6. Tam S, Blumenstein H, Wong JTE. 1978. Blood replacement in dogs by dextran-hemoglobin. Can. J. Biochem. 56:981-84
7. 7. Chatterjee R, Welty EV, Walder RY, et al. 1986. Isolation and characterization of a new hemoglobin derivative crosslinked between a chains (Lysine 99a1-Lysine 99a2). J Biol. Chem. 261:9929-37
8. 8. Hess JR, MacDonald VW, Brinkley WW. 1993. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74:1769-78
9. 9. Hoffman SJ, Looker DL, Roehrich JM, et al. 1990. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc. Nat. Acad. Sci. USA 87: 8521-25
10. 10. Looker D, Abbott-Brown D, Cozart P, et al. 1992. A human recombinant haemoglobin designed for use as a blood substitute. Nature 356:258-60
11. 11. Murray JA, Ledlow S, Launspach J, et al. 1995. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109: 1241-48
12. 12. Gould SA, Sehgal LR, Sehgal HL, Moss GS. 1995. The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions. Transfus. Sci. 16: 5-17
13. 13. Hsia JC. 1989. Pasteurizable, freeze-driable hemoglobin-based blood substitute. U.S. Patent No. 4,857,636
14. 14. Lee R, Atsumi N, Jacobs EE, et al. 1989. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity. J. Surg. Res. 47:407-11
15. 15. Hughes GS Jr, Francom SF, Antal EJ, et al. 1995. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J. Lab. Clin. Med. 126:441-51
16. 16. Kasper S-M, Walter M, Grune F, et al. 1996. Effects of a hemoglobin-based oxygen carrier (HBOC-201 ) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Cardiovasc. Anesth. 83:921-27
17. 17. Flaim SF. 1997. Perflubron-based emulsion: efficacy as temporary oxygen carrier. In Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges, ed. RM Winslow, KD Vandegriff, M Intaglietta, 6:91-132. Boston: Birkhauser. 336 pp.
18. 18. Kaufman RJ. 1995. Clinical development of perfluorocarbon-based red cell substitutes. In Blood Substitutes: Physiological Basis of Efficacy, ed. RM Winslow, KD Vandegriff, M Intaglietta, 5:53-75. Boston: Birkhauser. 205 pp.
19. 19. Centers for Biologics Evaluation and Research. 1991. Points to consider in the safety and evaluation of hemoglobin-based oxygen carriers. Transfusion 31: 369-71
20. 20. Centers for Biologics Evaluation and Research. 1994. Points to consider on efficacy evaluation of hemoglobin-and perfluorocarbon-based oxygen carriers. Transfusion 34:712-13
21. 21. Fratantoni J. 1995. Demonstration of the efficacy of a therapeutic agent. In Blood Substitutes: Physiological Basis of Efficacy, ed. RM Winslow, KD Vandegriff, M Intaglietta, 2:20-24. Boston: Birkhauser. 205 pp.
22. 22. Hess JR, Riess RF. 1996. Resuscitation and the limited utility of the present generation of blood substitutes. Transfus. Med. Rev. 10:276-85
23. 23. Przybelski RJ, Daily EK, Birnbaum ML. 1997. The pressor effect of hemoglobin - good or bad? In Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges, ed. RM Winslow, KD Vandegriff, M Intaglietta, 5:71-90. Boston: Birkhauser. 336 pp.
24. 24. Hager S, Gonzales A, Gonzales M, Winslow RM. 1996. Erythropoietin response to blood substitutes: a model for tissue hypoxia. Blood 88:184a (Abstr.)
25. 25. Suit H. 1995. Tumor oxygenation and radiosensitivity. In Blood Substitutes: Physiological Basis of Efficacy, ed. RM Winslow, KD Vandegriff, M Intaglietta, 13:187-99. Boston: Birkhauser. 205 pp.
26. 26. Federspiel WJ, Popel AS. 1986. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc. Res. 32:164-89
27. 27. Deleted in proof
28. 28. Vaughan P. 1996. Creutzfeldt-Jacob disease latest unknown in struggle to restore faith in blood supply. Can. Med. J. 155: 565-68
29. 29. Homer LD, Weathersby PK, Kiesow LA. 1981. Oxygen gradients between red blood cells in the microcirculation. Microvasc. Res. 22:308-23
30. 30. Intaglietta M, Johnson PC, Winslow RM. 1996. Microvascular and tissue oxygen distribution. Cardiovasc. Res. 32:632-43
31. 2 uptake of working in situ dog muscle. Adv. Exp. Med. Biol. 361:375-78
32. 32. Biro GP, Anderson PJ, Curtis SE, Cain SM. 1991. Stroma-free hemoglobin: its presence in plasma does not improve oxygen supply to the resting hindlimb vascular bed of hemodiluted dogs. Can. J. Physiol. Pharmacol 69:1656-62
33. 2 uptake of in situ dog muscle working maximally. J. Appl. Physiol. 361:2470-75
34. 34. Furchgott RF, Martin W, Cherry PD. 1985. Blockade of endothelium-dependent vasodilatation by hemoglobin: a possible factor in vasospasm associated with hemorrhage. Adv. Prostaglandin Thromboxane Leukotriene Res. 15:499-502
35. 35. Lemon DD, Doherty DH, Curry SR, et al. 1996. Control of the nitric oxide-scavenging activity of hemoglobin. Artif. Cells, Blood Substit., Immobil. Biotechnol. 24:378
36. 36. Jia L, Bonaventura J, Stamler JS. 1996.5-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221-26
37. 37. Rohlfs RJ, Bruner F, Chiu A, et al. 1998. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J. Biol. Chem. 273: 12128-34
38. 2 measurement by phosphorescence decay method. Am. J. Physiol. 265:H1434-38
39. 39. Saltzman D, DeLano FA, Schmid-Schoenbein GW. 1992. The microvasculature in skeletal muscle. VI. Adrenergic innervation of arterioles in normotensive and spontaneously hypertensive rats. Microvasc. Res. 44:263-73
40. 40. Winslow RM, Gonzales A, Gonzales ML, et al. 1998. Vascular resistance and the efficacy of red cell substitutes. J. Appl. Physiol. In press
41. 41. Tomasulo P. 1995. Transfusion alternatives: impact on blood banking worldwide. In Blood Substitutes: Physiological Basis of Efficacy, ed. RM Winslow, KD Vandegriff, M Intaglietta, 1:1-19. Boston: Birkhauser. 205 pp.